Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences Texas Tech University, Lubbock, TX, USA.
Internal Medicine, Cell Biology and Biochemistry, Neuroscience/Pharmacology and Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
J Alzheimers Dis. 2019;72(s1):S71-S79. doi: 10.3233/JAD-190808.
Type 2 diabetes mellitus (T2D), which is often accompanied by hyperinsulinemia and insulin resistance, is associated with an increased risk for developing mild cognitive impairment and Alzheimer's disease (AD); however, the underlying mechanisms for this association are still unclear. Recent findings have shown that hyperinsulinemia and insulin resistance can coexist or be independent events. This makes it imperative to determine the contribution of these individual conditions in impacting AD. This literature review highlights the recent developments of hyperinsulinemia and insulin resistance involvement in the progression and pathogenesis of AD.
2 型糖尿病(T2D)常伴有高胰岛素血症和胰岛素抵抗,与发生轻度认知障碍和阿尔茨海默病(AD)的风险增加有关;然而,这种关联的潜在机制尚不清楚。最近的研究结果表明,高胰岛素血症和胰岛素抵抗可以共存或独立发生。这使得确定这些个体情况对 AD 的影响变得至关重要。本文献综述强调了高胰岛素血症和胰岛素抵抗在 AD 进展和发病机制中的作用的最新进展。